参考文献/References:
［1］BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA-A Cancer Journal for Clinicians, 2018, 68(6): 394-424.
［2］KOLIOPOULOS G, NYAGA V N, SANTESSO N A, et al. Cytology versus HPV testing for cervical cancer screening in the general population ［J］. Cochrane Database of Systematic Reviews, 2017(8): CD 008587.
［3］LI Shuang, HU Ting, LV Weiguo, et al. Changes in prevalence and clinical characteristics of cervical cancer in the People's Republic of China: a study of 10,012 cases from a nationwide working group ［J］. The Oncologist, 2013, 18(10): 1101-1107.
［4］HO G Y, BIERMAN R, BEARDSLEY L, et al. Natural history of cervicovaginal papillomavirus infection in young women ［J］. The New England Journal of Medicine, 1998, 338(7): 423-428.
［5］CLARKE M A, GRADISSIMO A, SCHIFFMAN M, et al. Human papillomavirus DNA methylation as a biomarker for cervical precancer: consistency across 12 genotypes and potential impact on management of HPV-positive women ［J］. Clinical Cancer Research, 2018, 24(9): 2194-2202.
［6］Louvanto K, Aro K, Nedjai B, et al. Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia ［J］. Clin Infect Dis, 2019，ciz 677.
［7］OJESINA A I, LICHTENSTEIN L, FREEMAN S S, et al. Landscape of genomic alterations in cervical carcinomas ［J］. Nature, 2014, 506(7488): 371-375.
［8］HU Zheng, ZHU Da, WANG Wei, et al. Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism ［J］. Nature Genetics, 2015, 47(2): 158-163.
［9］WANG Li-ming, SHEN Hui, FENG Bei, et al. Reduction in the copy number and expression level of the recurrent human papillomavirus integration gene fragile histidine triad (FHIT) predicts the transition of cervical lesions ［J］. PLOS One, 2017, 12(4): e 0175520.
［10］Lee SI, Atri M. 2018 FIGO staging system for uterine cervical cancer:enter cross-sectional imaging ［J］. Radiology, 2019, 292(1): 15-24.
［11］张冬雅，郭红军．18 F-FDG PET-CT联合血清SCC-Ag检测对宫颈癌盆腔淋巴结转移的诊断价值 ［J］．中国CT和MRI杂志，2019，17（3）：105-108．
［12］ZHOU Juan, RAN Jing, HE Zhen-yu, et al. Tailoring pelvic lymphadenectomy for patients with stage IA2, IB1, and IIA1 uterine cervical cancer ［J］. Journal of Cancer, 2015, 6(4): 377-381.
［13］DARGENT D, MARTIN X, MATHEVET P. Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer ［J］. Gynecologic Oncology, 2000, 79(3): 411-415.
［14］刘开江，吕欣炜，刘青，等．纳米炭在腹腔镜下宫颈癌前哨淋巴结检测中的应用 ［J］．中国医学科学院学报，2013，35（2）：150-154．
［15］RYCHLIK A, MARIN S, DE SANTIAGO J A. Utility of laparoscopic indocyanine Green-Guided sentinel node biopsy in open cervical cancer surgery ［J］. International Journal of Gynecological Cancer, 2016, 26(7): 1288-1289.
［16］ALTGASSEN C, HERTEL H, BRANDSTAEDT A A, et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO study group ［J］. Journal of Clinical Oncology, 2008, 26(18): 2943-2951.
［17］LCURU F, MATHEVET P, QUERLEU D, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study ［J］. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology, 2011, 29(13): 1686-1691.
［18］李佩佩，盛修贵，郭慧，等．前哨淋巴结活检对382例临床早期宫颈癌盆腔淋巴结转移及预后评估价值 ［J］．中华肿瘤防治杂志，2019，26（9）：647-653．
［19］王庚．比较分析宫颈癌诊治中的过度治疗与治疗不足 ［J］．中国医药指南，2015，13（13）：292-293．
［20］HU Zheng, DING Wen-cheng, ZHU Da, et al. TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy ［J］. Journal of Clinical Investigation, 2015, 125(1): 425-436.
［21］DING Wen-cheng, HU Zheng, ZHU Da, et al. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-Positive cervical cancer cells ［J］. Clinical Cancer Research, 2014, 20(24): 6495-6503.
［22］ZHEN Shuai, LU Jiao-jiao, WANG Li-jie, et al. In vitro and in vivo synergistic therapeutic effect of cisplatin with human papillomavirus 16 E 6/E 7 CRISPR/Cas9 on cervical cancer cell line ［J］. Translational Oncology, 2016, 9(6): 498-504.
［23］Ren C, Wang H, Ding W, et al. Zinc Finger Nuclease Combines with Cisplatin and Trichostatin A Enhances the Antitumor Potency in Cervical Cancer Cells ［J］. Anticancer Agents Med Chem, 2019.
［24］ZHU Da, SHEN Hui, TAN Song-wei, et al. Nanoparticles based on poly (beta-Amino ester) and HPV16-Targeting CRISPR/shRNA as potential drugs for HPV16-Related cervical malignancy ［J］. Molecular Therapy, 2018, 26(10): 2443-2455.
［25］CHUNG H C, ROS W, DELORD J P, et al. Efficacy and safety of pembrolizumab in previously treated advanced cervical cancer:results from the phase II KEYNOTE-158 study ［J］. Journal of Clinical Oncology, 2019, 37(17): 1470-1478.
［26］STEVANOVIC S, DRAPER L M, LANGHAN M M, et al. Complete regression of metastatic cervical cancer after treatment with human papillomavirus-targeted tumor-infiltrating T cells ［J］. Journal of Clinical Oncology, 2015, 33(14): 1543-1550.
相似文献/References:
[1]冯学宇,乔银川,王好宁,等.823例宫颈癌机会性筛查结果分析[J].中国计划生育和妇产科,2010,(01):0.
FENG Xue-yu,QIAO Yin-chuan,WANG Hao-ning ..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[2]刘佳汭.保留盆腔自主神经的宫颈癌根治性手术[J].中国计划生育和妇产科,2010,(02):0.
[3]甘玉杰,熊小英,蔡春芳,等.血清SCCA、CA125、CA19-9与高危型人乳头状瘤病毒在宫颈癌及癌前病变中的表达及意义[J].中国计划生育和妇产科,2010,(04):0.
GAN Yu-jie,XIONG Xiao-ying,CAI Chun-fang,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[4]肖春燕,陈桂珍,铁木帅龙,等.325例宫颈病变阴道镜检查结果分析[J].中国计划生育和妇产科,2010,(05):0.
XIAO Chun-yan,CHEN Gui-zhen,TIEMU-Shuailong.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(10):0.
[5]钟茜,赵霞.宫颈癌诊治中的过度治疗与治疗不足[J].中国计划生育和妇产科,2013,(02):0.
ZHONG Xi,ZHAO Xia,[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[6]安红梅,张雯,邓继红,等.昆明地区高危HPV病毒载量与宫颈病变和宫颈癌相关性[J].中国计划生育和妇产科,2013,(03):0.
AN Hong - mei,ZHANG Wen,DENG Ji - hong *,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[7]闵爱萍,谢桂清,冷开容,等.Hepsin、Maspin在宫颈疾病中的表达及其临床意义[J].中国计划生育和妇产科,2013,(06):0.
Min Ai-ping,Xie Gui-qing,Leng Kai-rong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(10):0.
[8]朱书力,李力.树突状细胞对宫颈癌作用的研究进展[J].中国计划生育和妇产科,2014,(03):0.
[9]闵爱萍.刺猬蛋白在宫颈癌组织中的表达及其临床意义[J].中国计划生育和妇产科,2014,(07):0.
MIN Ai-ping,[J].Chinese Journal of Family Planning & Gynecotokology,2014,(10):0.
[10]孙肖霞,王志莲,郝敏,等.胰岛素样生长因子轴与宫颈癌的相关性研究[J].中国计划生育和妇产科,2015,(05):0.